Results 21 to 30 of about 45,133 (250)

MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients

open access: yesPharmaceuticals, 2023
Oxaliplatin (OXAL) is a commonly used chemotherapy for treating colorectal cancer (CRC). A recent genome wide association study (GWAS) showed that a genetic variant (rs11006706) in the lncRNA gene MKX-AS1 and partnered sense gene MKX could impact the ...
Ricardo D. Gonzalez   +9 more
doaj   +1 more source

Antisense-strand transcription correlates with sense-strand reactivation.

open access: yes, 2023
(A) DESeq2-normalised counts for sense and antisense strand transcripts normalised to their maximum values. (B) DESeq2-normalised counts of reads aligned to the proviral sense or antisense-strand exons. Linear model fit with 95% confidence interval shown.
David S. Rueda (7879094)   +3 more
core   +1 more source

TNF-α plays a role in hepatocyte apoptosis in Niemann-Pick type C liver disease

open access: yesJournal of Lipid Research, 2009
Niemann-Pick type C (NPC) is a fatal autosomal recessive lysosomal storage disease clinically characterized by neurodegeneration and liver disease.
Victoria M. Rimkunas   +3 more
doaj   +1 more source

Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient

open access: yesFrontiers in Pain Research, 2022
Advances in our understanding of the biology of spinal systems in organizing and defining the content of exteroceptive information upon which higher centers define the state of the organism and its role in the regulation of somatic and automatic output ...
Jose De Andres   +14 more
doaj   +1 more source

CD4 expression decrease by antisense oligonucleotides. Inhibition of rat T CD4+ cell reactivity [PDF]

open access: yes, 2012
In previous studies, we have demonstrated the inhibition of CD4 expression in rat lymphocytes treated with phorbol myristate acetate (PMA) by antisense oligonucleotides (AS-ODNs) directed against the AUG start region of the cd4 gene.
Franch i Masferrer, Àngels   +6 more
core   +1 more source

Electroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle

open access: yesMolecular Therapy: Nucleic Acids, 2015
Peptide nucleic acid (PNA) is a synthetic DNA mimic that has shown potential for discovery of novel splice switching antisense drugs. However, in vivo cellular delivery has been a limiting factor for development, and only few successful studies have been
Camilla Brolin   +5 more
doaj   +1 more source

The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides

open access: yesPharmaceuticals, 2022
Nucleic acids play a central role in human biology, making them suitable and attractive tools for therapeutic applications. While conventional drugs generally target proteins and induce transient therapeutic effects, nucleic acid medicines can achieve ...
Miklós Bege, Anikó Borbás
doaj   +1 more source

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins [PDF]

open access: yesDiabetes & Metabolism Journal, 2022
Statins are the cornerstone of the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, even under optimal statin therapy, a significant residual ASCVD risk remains.
Kyuho Kim   +2 more
doaj   +1 more source

Downregulation of Akt1 Inhibits Anchorage-Independent Cell Growth and Induces Apoptosis in Cancer Cells

open access: yesNeoplasia: An International Journal for Oncology Research, 2001
The serine/threonine kinases, Akti/PKBα, Akt2/PKBβ, and Akt3/PKBγ, play a critical role in preventing cancer cells from undergoing apoptosis. However, the function of individual Akt isoforms in the tumorigenicity of cancer cells is still not well defined.
Xuesong Liu   +7 more
doaj   +1 more source

Antisense oligonucleotides [PDF]

open access: yesNeurology Genetics, 2019
There are few disease-modifying therapeutics for neurodegenerative diseases, but successes on the development of antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy and Duchenne muscular dystrophy predict a robust future for ASOs in medicine.
Scoles, Daniel R.   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy